vs
艾默生(EMR)与Smurfit Westrock(SW)财务数据对比。点击上方公司名可切换其他公司
Smurfit Westrock的季度营收约是艾默生的1.8倍($7.7B vs $4.3B),艾默生净利率更高(13.9% vs 0.8%,领先13.1%),艾默生同比增速更快(4.1% vs 0.7%),过去两年Smurfit Westrock的营收复合增速更高(61.2% vs -0.3%)
艾默生是总部位于美国密苏里州圣路易斯的世界500强跨国企业,业务涵盖工业自动化设备、暖通控制系统、精密测量仪器的研发制造,同时面向工业、商业、消费级市场提供工程服务及对应软件工程解决方案。
Smurfit Westrock plc是总部位于爱尔兰都柏林的企业,核心业务为生产瓦楞包装及各类纸制包装产品,公司股票同时在纽约证券交易所和伦敦证券交易所挂牌上市。
EMR vs SW — 直观对比
营收规模更大
SW
是对方的1.8倍
$4.3B
营收增速更快
EMR
高出3.4%
0.7%
净利率更高
EMR
高出13.1%
0.8%
两年增速更快
SW
近两年复合增速
-0.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $4.3B | $7.7B |
| 净利润 | $605.0M | $63.0M |
| 毛利率 | 53.2% | 16.4% |
| 营业利润率 | 17.8% | 3.3% |
| 净利率 | 13.9% | 0.8% |
| 营收同比 | 4.1% | 0.7% |
| 净利润同比 | 3.4% | 0.0% |
| 每股收益(稀释后) | $1.07 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
EMR
SW
| Q1 26 | — | $7.7B | ||
| Q4 25 | $4.3B | $7.6B | ||
| Q3 25 | $4.9B | $8.0B | ||
| Q2 25 | $4.6B | $7.9B | ||
| Q1 25 | $4.4B | $7.7B | ||
| Q4 24 | $4.2B | $7.5B | ||
| Q3 24 | $4.6B | $7.7B | ||
| Q2 24 | $4.4B | $3.0B |
净利润
EMR
SW
| Q1 26 | — | $63.0M | ||
| Q4 25 | $605.0M | $97.0M | ||
| Q3 25 | $637.0M | $246.0M | ||
| Q2 25 | $586.0M | $-28.0M | ||
| Q1 25 | $485.0M | $384.0M | ||
| Q4 24 | $585.0M | $146.0M | ||
| Q3 24 | $996.0M | $-150.0M | ||
| Q2 24 | $329.0M | $132.0M |
毛利率
EMR
SW
| Q1 26 | — | 16.4% | ||
| Q4 25 | 53.2% | 18.2% | ||
| Q3 25 | 51.9% | 19.6% | ||
| Q2 25 | 52.6% | 19.1% | ||
| Q1 25 | 53.5% | 20.6% | ||
| Q4 24 | 53.5% | 19.1% | ||
| Q3 24 | 51.3% | 17.6% | ||
| Q2 24 | 52.8% | 23.3% |
营业利润率
EMR
SW
| Q1 26 | — | 3.3% | ||
| Q4 25 | 17.8% | 5.1% | ||
| Q3 25 | 16.4% | 6.6% | ||
| Q2 25 | 16.1% | 3.2% | ||
| Q1 25 | 14.2% | 7.2% | ||
| Q4 24 | 18.6% | 5.3% | ||
| Q3 24 | 14.7% | 0.7% | ||
| Q2 24 | 10.4% | 8.2% |
净利率
EMR
SW
| Q1 26 | — | 0.8% | ||
| Q4 25 | 13.9% | 1.3% | ||
| Q3 25 | 13.1% | 3.1% | ||
| Q2 25 | 12.9% | -0.4% | ||
| Q1 25 | 10.9% | 5.0% | ||
| Q4 24 | 14.0% | 1.9% | ||
| Q3 24 | 21.6% | -2.0% | ||
| Q2 24 | 7.5% | 4.4% |
每股收益(稀释后)
EMR
SW
| Q1 26 | — | $0.12 | ||
| Q4 25 | $1.07 | $0.18 | ||
| Q3 25 | $1.12 | $0.47 | ||
| Q2 25 | $1.04 | $-0.05 | ||
| Q1 25 | $0.86 | $0.73 | ||
| Q4 24 | $1.02 | $-0.12 | ||
| Q3 24 | $1.74 | $-0.30 | ||
| Q2 24 | $0.57 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | $7.6B | $980.0M |
| 股东权益账面价值 | $20.3B | $18.1B |
| 总资产 | $41.9B | $45.2B |
| 负债/权益比越低杠杆越低 | 0.37× | 0.05× |
8季度趋势,按日历期对齐
现金及短期投资
EMR
SW
| Q1 26 | — | — | ||
| Q4 25 | — | $892.0M | ||
| Q3 25 | — | $851.0M | ||
| Q2 25 | — | $778.0M | ||
| Q1 25 | — | $797.0M | ||
| Q4 24 | — | $855.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $26.8K |
总债务
EMR
SW
| Q1 26 | — | $980.0M | ||
| Q4 25 | $7.6B | $13.4B | ||
| Q3 25 | $8.9B | $13.3B | ||
| Q2 25 | $8.3B | $13.3B | ||
| Q1 25 | $8.2B | $12.9B | ||
| Q4 24 | $6.6B | $12.5B | ||
| Q3 24 | $7.7B | $13.2B | ||
| Q2 24 | $7.1B | — |
股东权益
EMR
SW
| Q1 26 | — | $18.1B | ||
| Q4 25 | $20.3B | $18.3B | ||
| Q3 25 | $20.3B | $18.4B | ||
| Q2 25 | $19.9B | $18.3B | ||
| Q1 25 | $19.2B | $17.9B | ||
| Q4 24 | $20.5B | $17.4B | ||
| Q3 24 | $21.6B | $18.0B | ||
| Q2 24 | $20.8B | $14.5K |
总资产
EMR
SW
| Q1 26 | — | $45.2B | ||
| Q4 25 | $41.9B | $45.2B | ||
| Q3 25 | $42.0B | $45.6B | ||
| Q2 25 | $42.5B | $45.7B | ||
| Q1 25 | $42.0B | $44.6B | ||
| Q4 24 | $42.6B | $43.8B | ||
| Q3 24 | $44.2B | $45.0B | ||
| Q2 24 | $45.6B | $26.8K |
负债/权益比
EMR
SW
| Q1 26 | — | 0.05× | ||
| Q4 25 | 0.37× | 0.73× | ||
| Q3 25 | 0.44× | 0.72× | ||
| Q2 25 | 0.42× | 0.73× | ||
| Q1 25 | 0.42× | 0.72× | ||
| Q4 24 | 0.32× | 0.72× | ||
| Q3 24 | 0.36× | 0.73× | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $699.0M | $204.0M |
| 自由现金流经营现金流 - 资本支出 | $602.0M | — |
| 自由现金流率自由现金流/营收 | 13.9% | — |
| 资本支出强度资本支出/营收 | 2.2% | — |
| 现金转化率经营现金流/净利润 | 1.16× | 3.24× |
| 过去12个月自由现金流最近4个季度 | $4.4B | — |
8季度趋势,按日历期对齐
经营现金流
EMR
SW
| Q1 26 | — | $204.0M | ||
| Q4 25 | $699.0M | $1.2B | ||
| Q3 25 | $3.1B | $1.1B | ||
| Q2 25 | $1.1B | $829.0M | ||
| Q1 25 | $241.0M | $235.0M | ||
| Q4 24 | $777.0M | $781.0M | ||
| Q3 24 | $3.3B | $320.0M | ||
| Q2 24 | $1.1B | $340.0M |
自由现金流
EMR
SW
| Q1 26 | — | — | ||
| Q4 25 | $602.0M | $612.0M | ||
| Q3 25 | $2.7B | $523.0M | ||
| Q2 25 | $977.0M | $307.0M | ||
| Q1 25 | $154.0M | $-242.0M | ||
| Q4 24 | $694.0M | $212.0M | ||
| Q3 24 | $2.9B | $-192.0M | ||
| Q2 24 | $998.0M | $163.0M |
自由现金流率
EMR
SW
| Q1 26 | — | — | ||
| Q4 25 | 13.9% | 8.1% | ||
| Q3 25 | 54.9% | 6.5% | ||
| Q2 25 | 21.5% | 3.9% | ||
| Q1 25 | 3.5% | -3.2% | ||
| Q4 24 | 16.6% | 2.8% | ||
| Q3 24 | 63.1% | -2.5% | ||
| Q2 24 | 22.8% | 5.5% |
资本支出强度
EMR
SW
| Q1 26 | — | — | ||
| Q4 25 | 2.2% | 7.7% | ||
| Q3 25 | 8.9% | 7.6% | ||
| Q2 25 | 2.0% | 6.6% | ||
| Q1 25 | 2.0% | 6.2% | ||
| Q4 24 | 2.0% | 7.5% | ||
| Q3 24 | 9.1% | 6.7% | ||
| Q2 24 | 2.1% | 6.0% |
现金转化率
EMR
SW
| Q1 26 | — | 3.24× | ||
| Q4 25 | 1.16× | 12.32× | ||
| Q3 25 | 4.86× | 4.61× | ||
| Q2 25 | 1.83× | — | ||
| Q1 25 | 0.50× | 0.61× | ||
| Q4 24 | 1.33× | 5.35× | ||
| Q3 24 | 3.35× | — | ||
| Q2 24 | 3.31× | 2.58× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EMR
| Other | $1.8B | 41% |
| Software And Systems | $1.0B | 24% |
| Intelligent Devices | $996.0M | 23% |
| Safety And Productivity | $503.0M | 12% |
SW
暂无分部数据